科研动态期刊摘要
司美格鲁肽对射血分数保留的心力衰竭合并肥胖患者血流动力学的影响：一项安慰剂对照随机临床试验
Nature Medicine · 2026-11-08
摘要
《自然·医学》，在线发表：2026年11月8日；doi:10.1038/s41591-026-04762-3 如2026年美国心脏协会科学年会上所报告，在一项安慰剂对照随机临床试验中，司美格鲁肽显著改善了射血分数保留的心力衰竭合并肥胖患者在低强度运动期间的肺动脉楔压及其他血流动力学参数。
English
Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial
Nature Medicine, Published online: 08 November 2026; doi:10.1038/s41591-026-04762-3 As presented at the 2026 American Heart Association Scientific Sessions, in a placebo-controlled randomized clinical trial, semaglutide significantly improved pulmonary artery wedge pressure and other hemodynamic parameters during low-intensity exercise in individuals with heart failure with preserved ejection fraction and obesity.